Patent Assignment
Reel/Frame 039601/0423
Confirmatory License
Recorded: 2016-08-08
Pages: 2
Assignor
DANA-FARBER CANCER INST
Executed: 2016-04-27
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom
Application:
09/951,938 →
Publication:
US 2005/0053606
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 4, 2002
From: KUFE, DONALD W.; OHNO, TSUNEYA
To: ILEX ONCOLOGY, INC.; DANA FARBER CANCER INSTITUTTE
Reel/Frame 012600/0627 →
Assignment of Assignor's Interest
Sep 9, 2003
From: ILEX ONCOLOGY, INC.
To: ILEX PRODUCTS, INC.
Reel/Frame 013951/0904 →
Merger
Feb 19, 2007
From: ILEX PRODUCTS, INC.
To: GENZYME CORPORATION
Reel/Frame 018903/0447 →
Confirmatory License
Sep 21, 2016
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 039810/0423 →